Premium
Improving access to cancer clinical trials by reducing the financial burden
Author(s) -
Winkfield Karen M.
Publication year - 2020
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.32523
Subject(s) - medicine , clinical trial , cancer , intensive care medicine
Cancer clinical trials are vital to improving cancer care, but participation may add an additional financial burden for individuals and families already struggling to bear the high cost of cancer care. Finding sustainable ways to reduce financial toxicity, particularly for low‐ and middle‐income patients, may help to improve clinical trial recruitment and retention.